ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ETON Eton Pharmaceuticals Inc

3.45
0.33 (10.58%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Eton Pharmaceuticals Inc ETON NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.33 10.58% 3.45 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.14 3.14 3.67 3.45 3.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/3/202401:00GLOBEEton Pharmaceuticals Announces Acquisition of PKU GOLIKE®..
14/3/202415:01GLOBEEton Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202415:01GLOBEEton Pharmaceuticals to Report Fourth Quarter and Full Year..
21/2/202405:55EDGAR2Form 8-K - Current report
21/2/202405:50GLOBEEton Pharmaceuticals Awarded U.S. Patent for Proprietary..
15/2/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202405:55EDGAR2Form 8-K - Current report
02/2/202405:50GLOBEEton Pharmaceuticals Announces Commercial Availability of..
09/11/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:01GLOBEEton Pharmaceuticals Reports Third Quarter 2023 Financial..
30/10/202305:50GLOBEEton Pharmaceuticals to Report Third Quarter 2023 Financial..
18/10/202307:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
04/10/202305:55EDGAR2Form 8-K - Current report
04/10/202305:50GLOBEEton Pharmaceuticals Announces Acquisition of FDA-Approved..
23/8/202305:50GLOBEEton Pharmaceuticals to Present at the H.C. Wainwright 25th..
10/8/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:15EDGAR2Form 8-K - Current report
10/8/202315:01GLOBEEton Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202315:05GLOBEEton Pharmaceuticals to Report Second Quarter 2023 Financial..
17/7/202315:05PRNUSSWK Holdings Highlights Recent Achievements and Provides..
28/6/202306:42DJNEton Pharma Gets FDA Complete Response Letter for Dehydrated..
28/6/202305:50GLOBEEton Pharmaceuticals Receives Complete Response Letter (CRL)..
11/5/202315:01GLOBEEton Pharmaceuticals Reports First Quarter 2023 Financial..
10/5/202305:50GLOBEEton Pharmaceuticals Announces Commercial Availability of..
03/5/202315:05GLOBEEton Pharmaceuticals to Report First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock